Compliance with topical nasal medication - An evaluation in children with rhinitis

Pediatric Allergy and Immunology

Volumn 21, Issue 8, 2010, Pages 1146-1150

  Wong, Ivy Y Z ^a   Soh, S E ^a   Chng, Seo Y ^a   Shek, Lynette P C ^a   Goh, Daniel Y T ^a   Van Bever, Hugo P S ^a   Lee, B W ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Acceptance; Children; Rhinitis; Topical nasal medication

Indexed keywords

NOSE SPRAY;

ALLERGIC RHINITIS; ARTICLE; CHILD; CHINESE; CLINICAL EVALUATION; ETHNICITY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; SCHOOL CHILD; STRUCTURED QUESTIONNAIRE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MALE; PATIENT COMPLIANCE; PATIENT PREFERENCE; QUESTIONNAIRES; RHINITIS; SINGAPORE;

EID: 78449264143     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2010.01015.x     Document Type: Article

References (29)

1. DeJarnatt AC, Grant AJ. Basic mechanisms of anaphylaxis and anaphylactoid reactions. Immunol Allergy Clin North Am 1992: 12: 501-515.
2. Hagemann TM. Pediatric Allergic Rhinitis Drug Therapy: Background and Epidemiology. J Pediatr Health Care 2005: 19: 238-244.
3. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001: 86: 494-507.
4. Goh DY, Chew FT, Quek SC, Lee BW. Prevalence and severity of asthma, rhinitis, and eczema in Singapore schoolchildren. Arch Dis Child 1996: 74: 131-135.
5. Bachert C, Van Cauwenberge P, Khaltaev N, World Health Organization. Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy 2002: 57: 841-55.
6. Pullerits T, Praks L, Ristioja V, et al. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002: 109: 949-955.
7. Hauschildt E. Intranasal Glucocorticoids Most Effective In Seasonal Allergic Rhinitis. J Allergy Clin Immunol 2002: 109: 949-955.
8. Richards DH, Milton CM. Fluticasone propionate aqueous nasal spray: a well-tolerated and effective treatment for children with perennial rhinitis. Pediatr Allergy Immunol 2007: 7: 35-43.
9. Meltzer EO, Lee J, Tripathy I, Lim J, Ellsworth A, Philpo E. Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. Pediatr Allergy Immunol 2008: 20: 279-286.
10. Kaszuba SM, Baroody FM, M, et al. Superiority of an intranasalcorticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Int Med 2001: 161: 2581-7.
11. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998: 317: 1624-9.
12. Sciarra JJ. Aerosol Suspensions and Emulsions, In: Pharmaceutical Dosage Forms: Disperse System, Vol. 2. 2nd edn. New York: Informa Health Care, 1996: 321.
13. Chatkin JM, Cavalet-Blanco D, Scaglia NC, Tonietto RG, Wagner MB, Fritscher CC. Compliance with maintenance treatment of asthma (ADERE study). J Bras Pneumol 2006: 32: 277-83.
14. Chrystyn H. The Diskus: a review of its position among dry powder inhaler devices. Int J Clin Pract 2007: 61: 1022-36.
15. Moller M, Fritsche D, Rivera D, Libertus H. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler. Arzneimittelforschung 2003: 53: 562-567.
16. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled Corticosteroids for Asthma Therapy: Patient Compliance, Devices, and Inhalation Technique. Chest 2000: 117: 542-550.
17. Kunkel G, Schaper C, Noga O, Schlafke S, Lemmnitz G, Kohler S. Efficacy, safety, and acceptance of beclomethasone dipropionate administered via a new dry powder Inhaler or a standard CFC metered-dose inhaler in asthma patients. Respiration 2003: 70: 399-406.
18. Ahonen A, Leinonen M, Ranki-Pesonen M. Patient satisfaction with Easyhaler® compared with other inhalation systems in the treatment of asthma: a meta-analysis. Curr Ther Res 1999: 61: 74-82.
19. Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev 2005: 14: 109-116.
20. Inhaler Devices for Asthma. Drug Ther Bull 2000: 38: 9-14.
21. Nielsen K, Okamoto L, Shah T. Importance of Selected Inhaler Characteristics and Acceptance of a New Breath-Actuated Powder Inhalation Device. J Asthma 1997: 34: 249-53.
22. Conway A. Adherence and compliance in the management of asthma: 1. Br J Nurs 1998: 7: 1313-1315.
23. Zhao X, Furber S, Bauman A. Asthma Knowledge and Medication Compliance Among Parents of Asthmatic Children in Nanjing, China. J Asthma 2002: 39: 743-747.
24. Foland AP, Stern T, Ramacciotti T, Martin J, Gilbert I, Cohn R.C. Improvement of metered-dose inhaler administration technique: the effect of training sessions at a specialized pediatric asthma compliance and technique clinic. Curr Ther Res 2002: 63: 142-147.
25. Baum D, Creer TL. Medication Compliance in Children with Asthma. J Asthma 1996: 39: 743-747.
26. Small P, Houle P, Day JH, et al. A comparison of triamcinolone acetonide nasal aerosol spray and fluticasone propionate aqueous solution spray in the treatment of spring allergic rhinitis. J Allergy Clin Immunol 1997: 100: 592-595.
27. Meltzer EO, Derebery MJ, Boyle JM, Droar J. Intranasal corticosteroids that provide a rapid onset of action and 24-hour symptom relief may improve satisfaction with therapy in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2007: 98 (S1): A117-8.
28. Shah A. Current Categorisation of Allergic Rhinitis and Sensory Perceptions to Intranasal Corticosteroids: Clinical Implications. Indian J Chest Dis Allied Sci 2005: 47: 157-159.
29. Loh CY, Chao SS, Chan YH, Wang DY. A clinical survey on compliance in the treatment of rhinitis using nasal steroids. Allergy 2004: 59: 1168-1172.